Disease-associated alterations of enzymatic functions are potentially useful as disease biomarkers, and here we show that an enzymomics (omics of active enzymes) approach, in which enzymatic activities are screened with panels of substrates, can be an effective way to identify such alterations. In the present study, we used a panel of fluorogenic substrates to search for altered enzyme activities in bronchoalveolar lavage fluid (BALF) from a mouse model of lung inflammation. We found that acylamino acid releasing enzyme (APEH) activity was highly elevated, apparently reflecting the increased population of immune cells in the inflamed lung.Key words chemical biology; fluorescent probe; enzymomics; biomarker; lung inflammation Cellular functions are mediated by various enzymes, and altered enzymatic functions are often observed during disease onset and progression. Such changes can be helpful for clinical diagnosis and monitoring, and therefore there is great interest in the discovery of novel biomarker candidates. Various types of omics studies (e.g., proteomics, metabolomics) have been used to find biomarkers, but altered enzymatic activity is not always observable with widely used omics platforms.1,2) For example, changes in protein expression level are not always reflected in functional activity, since protein functions are regulated dynamically by multiple factors, including posttranslational modifications, protein-protein interactions, and intrinsic inhibitors.1) Since enzymatic activities in bio-fluids are often measured for diagnostic purposes (e.g., alkaline phosphatases [3][4][5] and gamma-glutamyl transferases [6][7][8] ), a better strategy might be to directly screen for altered enzymatic activities in those bio-samples. This approach can be termed enzymomics (omics of active enzymes).For this purpose, two key technologies are required: firstly, a method to simultaneously monitor multiple enzymatic activities towards a range of substrates, and secondly, a method to identify target proteins exhibiting activities of interest. In this study, we developed a panel of fluorogenic substrates to read out the enzymatic activities of various peptidases, and used it to search for altered enzymatic activities in bronchoalveolar lavage fluid (BALF) from a mouse model of lung inflammation induced by lipopolysaccharide (LPS) and formyl peptide formyl-methionyl-leucyl-phenylalanine (fMLF) (Fig. 1). We found that one of the substrates showed a strongly enhanced fluorescence signal in inflammatory BALF. We then identified the enzyme mediating this activity by means of our recently developed diced electrophoresis gel (DEG) assay. In DEG assay, enzymatic activities are detected after two-dimensional native electrophoresis-based separation of the proteome, and the target protein exhibiting the activity is identified by protein identifying technologies like LC-MS/MS.
9-11)BALF is already used in diagnosis of airway diseases, and elastase is well established as one of the biomarkers of lung inflammation.12,13) Increased elas...